About Contact Us Careers
Sign In

Non Invasive Prenatal Testing Market Trends

  • Report ID: 6309
  • Published Date: Aug 08, 2024
  • Report Format: PDF, PPT
  1. An Outline of the Global Non-Invasive Prenatal Testing (NIPT) Market
    1. Study Objective
    2. Market Definition
    3. Market Segmentation
  1. Assumptions and Abbreviations
  2. Research Process
    1. SPSS Methodology
    2. Primary Research
      1. Manufacturers
      2. End Users
    3. Secondary Research
    4. Market Size Estimation
  3. Executive Summary
  4. Opportunities
  5. Growth Drivers
  6. Major Roadblocks
  7. Trends
  8. Government Regulation: How They Would Aid Business?
  9. Up-Coming Technologies
  10. Growth Outlook
  11. Risk Analysis
  12. SWOT
  13. Merger and Acquisitions
  14. Application Analysis
  15. Regional Demand
  16. Recent News
  17. Technology Analysis
  18. End User Analysis
  19. Non-Invasive Prenatal Testing (NIPT) Uptake by Pregnancy Risk Level Analysis
  20. Comparative Positioning
  21. Competitive Landscape: Global Key Players
    1. Company Market Share
    2. Business Profile of Key Enterprise
      1. Centogene N.V.
        1. Detailed Overview
        2. Assessment of key offerings
        3. Analysis of growth strategies
        4. Exhaustive analysis on key financial indicators
        5. Recent developments and strategies
      2. CRIFM Prenatal Medical Clinic
      3. Eurofins LifeCodexx GmbH
      4. MedGenome Labs Ltd.
      5. NIPT Hiro Clinic
      6. FALCO biosystems Ltd.
      7. Biora Therapeutics,Inc.(Progenity,Inc.)
      8. F. Hoffmann-La Roche Ltd.
      9. Illumina Inc.
      10. Laboratory Corporation of America Holdings.
      11. Natera Inc.
      12. Myriad Women’s Health, Inc.
      13. QIAGEN
      14. Quest Diagnostics
      15. CooperSurgical, Inc. 
  22. Global Non-Invasive Prenatal Testing (NIPT) Market Outlook
    1. Market Overview
    2. Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
    3. Global Non-Invasive Prenatal Testing (NIPT) Market Segmentation Analysis (2024-2037)
      1. By Gestational Age
        1. 0-12 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. 13-24 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. 25–36 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      2. By Pregnancy Risk
        1. High risk vs. average risk, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Low-risk Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      3. By Method
        1. Biochemical Screening Tests, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Maternal cell-free DNA, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. Plasma Testing, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        4. Ultrasonic Detection, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      4. By Technology
        1. Next-generation sequencing (NGS), Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Array Technology, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. Polymerase Chain Reaction (PCR), Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      5. By Product
        1. Consumables and Reagents, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Device, Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      6. By Application
        1. Trisomy, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Microdeletion syndromes, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. Others, Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      7. By End user
        1. Hospitals and Clinics, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Diagnostic Laboratories, Market Value (USD Million), and CAGR, 2024-2037F
      8. By Region
        1. North America Market Value (USD Million), and CAGR, 2024-2037F
        2. Europe Market Value (USD Million), and CAGR, 2024-2037F
        3. Asia Pacific Excluding Japan Market Value (USD Million), and CAGR, 2024-2037F
        4. Japan Market Value (USD Million), and CAGR, 2024-2037F
        5. Latin America Market Value (USD Million), and CAGR, 2024-2037F
        6. Middle East and Africa Market Value (USD Million), and CAGR, 2024-2037F

 

Cross Analysis of End User W.R.T. Technology (USD Million), 2024-2037   

  1. North America Non-Invasive Prenatal Testing (NIPT) Market Outlook
    1. Market Overview
    2. Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
    3. North America Non-Invasive Prenatal Testing (NIPT) Market Segmentation Analysis (2024-2037)
      1. By Gestational Age
        1. 0-12 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. 13-24 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. 25–36 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      2. By Pregnancy Risk
        1. High risk vs. average risk, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Low-risk Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      3. By Method
        1. Biochemical screening tests, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Maternal cell-free DNA, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. Plasma testing, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        4. Ultrasonic Detection, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      4. By Technology
        1. Next-generation sequencing (NGS), Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Array Technology, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. Polymerase Chain Reaction (PCR), Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      5. By Product
        1. Consumables and Reagents, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Device, Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      6. By Application
        1. Trisomy, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Microdeletion syndromes, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. Others, Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      7. By End user
        1. Hospitals and Clinics, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Diagnostic Laboratories, Market Value (USD Million), and CAGR, 2024-2037F
      8. By Country
        1. US Market Value (USD Million), and CAGR, 2024-2037F
        2. Canada Market Value (USD Million), and CAGR, 2024-2037F

 

Cross Analysis of End User W.R.T. Technology (USD Million), 2024-2037 

  1. Europe Non-Invasive Prenatal Testing (NIPT) Market Outlook
    1. Market Overview
    2. Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
    3. Europe Non-Invasive Prenatal Testing (NIPT) Market Segmentation Analysis (2024-2037)
      1. By Gestational Age
        1. 0-12 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. 13-24 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. 25–36 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      2. By Pregnancy Risk
        1. High risk vs. average risk, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2.  Low-risk Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      3. By Method
        1. Biochemical screening tests, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Maternal cell-free DNA, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. Plasma testing, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        4. Ultrasonic Detection, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      4. By Technology
        1. Next-generation sequencing (NGS), Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Array Technology, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. Polymerase Chain Reaction (PCR), Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      5. By Product
        1. Consumables and Reagents, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Device, Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      6. By Application
        1. Trisomy, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Microdeletion syndromes, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. Others, Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      7. By End User
        1. Hospitals and Clinics, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Diagnostic Laboratories, Market Value (USD Million), and CAGR, 2024-2037F
      8. By Country
        1. UK Market Value (USD Million), and CAGR, 2024-2037F
        2. Germany Market Value (USD Million), and CAGR, 2024-2037F
        3. France Market Value (USD Million), and CAGR, 2024-2037F
        4. Italy Market Value (USD Million), and CAGR, 2024-2037F
        5. Spain Market Value (USD Million), and CAGR, 2024-2037F
        6. BENELUX Market Value (USD Million), and CAGR, 2024-2037F
        7. Poland Market Value (USD Million), and CAGR, 2024-2037F
        8. Russia Market Value (USD Million), and CAGR, 2024-2037F
        9. Rest of Europe Market Value (USD Million), and CAGR, 2024-2037F

 

Cross Analysis of End User W.R.T. Technology (USD Million), 2024-2037  

  1. Asia Pacific excluding Japan Non-Invasive Prenatal Testing (NIPT) Market Outlook
    1. Market Overview
    2. Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
    3. Asia Pacific excluding Japan Non-Invasive Prenatal Testing (NIPT) Market Segmentation Analysis (2024-2037)
      1. By Gestational Age
        1. 0-12 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. 13-24 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. 25–36 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      2. By Pregnancy Risk
        1. High risk vs. average risk, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2.  Low-risk Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      3. By Method
        1. Biochemical screening tests, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Maternal cell-free DNA, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. Plasma testing, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        4. Ultrasonic Detection, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      4. By Technology
        1. Next-generation sequencing (NGS), Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Array Technology, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. Polymerase Chain Reaction (PCR), Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      5. By Product
        1. Consumables and Reagents, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Device, Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      6. By Application
        1. Trisomy, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Microdeletion syndromes, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. Others, Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      7. By End User
        1. Hospitals and Clinics, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Diagnostic Laboratories, Market Value (USD Million), and CAGR, 2024-2037F
      8. By Country
        1. China Market Value (USD Million), and CAGR, 2024-2037F
        2. India Market Value (USD Million), and CAGR, 2024-2037F
        3. ASEAN, Market Value (USD Million), and CAGR, 2024-2037F
        4. South Korea Market Value (USD Million), and CAGR, 2024-2037F
        5. Australia Market Value (USD Million), and CAGR, 2024-2037F
        6. New Zealand Market Value (USD Million), and CAGR, 2024-2037F
        7. Rest of Asia Pacific excluding Japan Market Value (USD Million), and CAGR, 2024-2037F

 

Cross Analysis of End User W.R.T. Technology (USD Million), 2024-2037

  1. Japan Non-Invasive Prenatal Testing (NIPT) Market Outlook
    1. Market Overview
    2. Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
    3. Japan Non-Invasive Prenatal Testing (NIPT) Market Segmentation Analysis (2024-2037)
      1. By Gestational Age
        1. 0-12 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. 13-24 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. 25–36 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      2. By Pregnancy Risk
        1. High risk vs. average risk, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2.  Low-risk Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      3. By Method
        1. Biochemical screening tests, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Maternal cell-free DNA, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. Plasma Testing, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        4. Ultrasonic Detection, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      4. By Technology
        1. Next-generation sequencing (NGS), Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Array Technology, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. Polymerase Chain Reaction (PCR), Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      5. By Product
        1. Consumables and Reagents, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Device, Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      6. By Application
        1. Trisomy, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Microdeletion syndromes, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. Others, Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      7. By End User
        1. Hospitals and Clinics, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Diagnostic Laboratories, Market Value (USD Million), and CAGR, 2024-2037F

 

Cross Analysis of End User W.R.T. Technology (USD Million), 2024-2037

  1. Latin America Non-Invasive Prenatal Testing (NIPT) Market Outlook
    1. Market Overview
    2. Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
    3. Latin America Non-Invasive Prenatal Testing (NIPT) Market Segmentation Analysis (2024-2037)
      1. By Gestational Age
        1. 0-12 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. 13-24 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. 25–36 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      2. By Pregnancy Risk
        1. High risk vs. average risk, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2.  Low-risk Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      3. By Method
        1. Biochemical screening tests, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Maternal cell-free DNA, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. Plasma testing, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        4. Ultrasonic Detection, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      4. By Technology
        1. Next-generation sequencing (NGS), Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Array Technology, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. Polymerase Chain Reaction (PCR), Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      5. By Product
        1. Consumables and Reagents, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Device, Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      6. By Application
        1. Trisomy, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Microdeletion syndromes, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. Others, Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      7. By End user
        1. Hospitals and Clinics, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Diagnostic Laboratories, Market Value (USD Million), and CAGR, 2024-2037F
      8. By Country
        1. Brazil Market Value (USD Million), and CAGR, 2024-2037F
        2. Argentina Market Value (USD Million), and CAGR, 2024-2037F
        3. Mexico Market Value (USD Million), and CAGR, 2024-2037F
        4. Rest of Latin America Market Value (USD Million), and CAGR, 2024-2037F

Cross Analysis of End user W.R.T. Technology (USD Million), 2024-2037

  1. Middle East & Africa Non-Invasive Prenatal Testing (NIPT) Market Outlook
    1. Market Overview
    2. Market Revenue by Value (USD Million) and Compound Annual Growth Rate (CAGR)
    3. Middle East & Africa Non-Invasive Prenatal Testing (NIPT) Market Segmentation Analysis (2024-2037)
      1. By Gestational Age
        1. 0-12 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. 13-24 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. 25–36 weeks, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      2. By Pregnancy Risk
        1. High risk vs. average risk, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2.  Low-risk Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      3. By Method
        1. Biochemical screening tests, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Maternal cell-free DNA, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. Plasma testing, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        4. Ultrasonic Detection, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      4. By Technology
        1. Next-generation sequencing (NGS), Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Array Technology, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. Polymerase Chain Reaction (PCR), Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      5. By Product
        1. Consumables and Reagents, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Device, Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      6. By Application
        1. Trisomy, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Microdeletion syndromes, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        3. Others, Market Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
      7. By End user
        1. Hospitals and Clinics, Value (USD Million) CAGR & Y-o-Y Growth Trend, 2024-2037F
        2. Diagnostic Laboratories, Market Value (USD Million), and CAGR, 2024-2037F
      8. By Country
        1. GCC Market Value (USD Million), and CAGR, 2024-2037F
        2. Israel Market Value (USD Million), and CAGR, 2024-2037F
        3. South Africa Market Value (USD Million), and CAGR, 2024-2037F
        4. Rest of Middle East & Africa Market Value (USD Million), and CAGR, 2024-2037F

Cross Analysis of End User W.R.T. Technology (USD Million), 2024-2037   

  1. Global Economic Scenario

Non Invasive Prenatal Testing Market Trends

Growth Drivers

  • Increasing demand for non-invasive prenatal testing (NIPT)- The popularity of non-invasive prenatal testing is witnessing an uptick through collaborative research and strategic public-private partnerships. Initiatives that incorporate NIPT into healthcare programs at the national level have acted in recognition of its potential to revolutionize prenatal care. As per National Institute of Health (NIH), NIPT will be much safer compared to the invasive diagnostic procedures of chorionic villus sampling and amniocentesis, which includes a small but significant miscarriage risk (0.1–0.2%). According to the International Society for Prenatal Diagnosis, the NIPT uptake significantly increases, reaching more than 85% among pregnant women in some developed countries by 2023.
  • Rising incidence of congenital disorders- Congenital disorders are among the major global health problems. According to the World Health Organization, in 2023, an estimated 265,000 newborn babies died during the neonatal period resulting from congenital anomalies. Congenital anomalies are disproportionately prevalent in low- and middle-income countries, with some studies estimating that up to 95% of cases of severe congenital disorders occur in these countries. This perhaps might result from unavailable health resources or prenatal screening.

    In 2020, a report by the NLM indicated an 8% increase in the global burden of congenital disorders since 2010. This growing need for accessible and accurate prenatal testing methods is expected to boost non invasive prenatal testing market growth in developing economies.

Challenges

  • High cost of non-invasive prenatal testing (NIPT)- The high cost of non-invasive prenatal testing (NIPT) remains a significant barrier to widespread adoption, particularly in developing countries. Despite technological advancements, the financial burden of these tests continues to limit accessibility for many expectant parents.

    An article published in the American Journal of Obstetrics and Gynecology shows that these out-of-pocket costs of NIPT vary from USD 100 at the lowest quote, ranging up to as high as USD 2,000 under various insurance coverage and provider policies within the United States itself. As a result, the price variability creates inequities in access and influences some major decisions with wide implications for prenatal care.
  • Regulatory landscape and health considerations- The regulatory framework for NIPT varies hugely across different countries or regions. On one hand, a strict and regulated environment is conducive to ensuring the quality of testing and patient safety; on the other hand, it definitely will bring challenges to the access to the non invasive prenatal testing market  and the innovation speed. For example, the FDA established in late 2022 a risk-based framework with which to regulate NIPT in a way that could simplify premarket reviews but also uphold their excellent standards. As a consequence, the implementation of the In Vitro Diagnostic Regulation (IVDR) in Europe has led to an escalation in the requirements for the validation of NIPT-market surveillance. 

Non Invasive Prenatal Testing Market: Key Insights

Base Year

2024

Forecast Year

2025-2037

CAGR

9.4%

Base Year Market Size (2024)

USD 4.5 Billion

Forecast Year Market Size (2037)

USD 14.5 Billion

Regional Scope
  • North America (United States and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, Brazil, India, Indonesia, South Korea, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (United Kingdom, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF
Browse Key Market Insights with Data Illustration:

Author Credits:  Radhika Pawar


  • Report ID: 6309
  • Published Date: Aug 08, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In 2024, the industry size of non invasive prenatal testing (NIPT) was USD 4.5 billion.

The global non invasive prenatal testing (NIPT) market size is projected to reach USD 4.5 billion in 2024 and is expected to secure USD 14.5 billion by the end of 2037, expanding at a CAGR of 9.4% during the forecast period, i.e., 2025-2037. In 2025, the industry size of non invasive prenatal testing (NIPT) will be valued at USD 4.9 billion.

Key players in the market are Illumina, Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Laboratory Corporation of America Holdings, and Natera, Inc.

The 13-24 weeks category is likely to hold the largest share of about 51.4% during 2025-2037.

North America is anticipated to provide lucrative prospects for expansion to the companies in the non invasive prenatal testing (NIPT) sector in the coming years.
Inquiry Before Buying Request Free Sample

Copyright © 2024 Research Nester. All Rights Reserved

logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample